ERJ Open Research

Contentshow allhide all

1. 2023

   • Vol. 9: Plasma levels of alpha1-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients

     Börner, Friedemann R.; Lechowicz, Urszula; Wrenger, Sabine; Martinez-Delgado, Beatriz; Olejnicka, Beata; Welte, Tobias; Chorostowska-Wynimko, Joanna; Kiehntopf, Michael; Janciauskiene, Sabina
2. 2022

   • Vol. 8: Pathogen spectra in hospitalised and nonhospitalised children with community acquired pneumonia

     Wetzke, Martin; Schütz, Katharina; Kopp, Matthias Volkmar; Seidenberg, Jürgen; Vogelberg, Christian; Ankermann, Tobias; Happle, Christine; Voigt, Gesche; Köster, Holger; Illig, Thomas; Lex, Christiane; Schuster, Antje; Maier, Ralph; Panning, Marcus; Barten, Grit; Rohde, Gernot; Welte, Tobias; Hansen, Gesine

   • Vol. 8: Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma

     Franceschi, Elisa; Drick, Nora; Fuge, Jan; Welte, Tobias; Suhling, Hendrik

   • Vol. 8: Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD

     p. 207

     Drick, Nora; Fuge, Jan; Seeliger, Benjamin; Speth, Milan; Vogel-Claussen, Jens; Welte, Tobias; Suhling, Hendrik
3. 2015

   • Vol. 4: Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis

     Rademacher, Jessica; Martin, Luise; Theloe, Anja; Stahl, Mirjam; Mall, Marcus A.; Joean, Oana; Fuge, Jan; Hansen, Gesine; Welte, Tobias; Schütz, Katharina; Ringshausen, Felix Christian; Dittrich, Anna M.